Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 13.62% is 87% above its 5-year average of 7.27%, near the high end of its 5-year range (0.92%–13.62%).
As of the fiscal period ended Wednesday, December 31, 2025. 7.67% above its 12-month average of 12.65%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
13.62%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
12.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
8.97%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
7.27%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
2.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-3.78%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-3.02%
CURRENT VS TTM AVG
+7.67%
CURRENT VS 3Y AVG
+51.84%
CURRENT VS 5Y AVG
+87.43%
CURRENT VS 10Y AVG
+537.80%
CURRENT VS 15Y AVG
+460.26%
CURRENT VS 20Y AVG
+550.32%
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+59.67%
vs the sector median at left
Insulet Corp.
Market Cap
$9.78B
Return on Invested Capital (ROIC)
13.62%
TTM Avg
12.65%
3Y Avg
8.97%
5Y Avg
7.27%
Market Cap
$10.04B
Return on Invested Capital (ROIC)
6.58%
TTM Avg
6.66%
3Y Avg
7.75%
5Y Avg
8.24%
Market Cap
$9.49B
Return on Invested Capital (ROIC)
2.04%
TTM Avg
2.21%
3Y Avg
2.35%
5Y Avg
2.39%
Market Cap
$10.25B
Return on Invested Capital (ROIC)
7.64%
TTM Avg
12.01%
3Y Avg
15.07%
5Y Avg
15.28%
Market Cap
$10.37B
Return on Invested Capital (ROIC)
-24.28%
TTM Avg
-15.13%
3Y Avg
-6.38%
5Y Avg
-2.73%
Market Cap
$9.12B
Return on Invested Capital (ROIC)
-10.90%
TTM Avg
-59.32%
3Y Avg
-58.49%
5Y Avg
-53.68%
Market Cap
$10.51B
Return on Invested Capital (ROIC)
11.29%
TTM Avg
10.92%
3Y Avg
8.93%
5Y Avg
9.01%
Market Cap
$11.32B
Return on Invested Capital (ROIC)
3.18%
TTM Avg
5.25%
3Y Avg
8.14%
5Y Avg
8.29%
Market Cap
$11.80B
Return on Invested Capital (ROIC)
10.58%
TTM Avg
10.99%
3Y Avg
9.48%
5Y Avg
9.31%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Insulet Corp. (PODD) | $9.78B | 13.62% | 12.65% | 8.97% | 7.27% |
| Henry Schein, Inc. (HSIC)vs › | $10.04B | 6.58% | 6.66% | 7.75% | 8.24% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.49B | 2.04% | 2.21% | 2.35% | 2.39% |
| Molina Healthcare, Inc. (MOH)vs › | $10.25B | 7.64% | 12.01% | 15.07% | 15.28% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -24.28% | -15.13% | -6.38% | -2.73% |
| Tempus AI, Inc. (TEM)vs › | $9.12B | -10.90% | -59.32% | -58.49% | -53.68% |
| Universal Health Services, Inc. (UHS)vs › | $10.51B | 11.29% | 10.92% | 8.93% | 9.01% |
| Bio-Techne Corporation (TECH)vs › | $11.32B | 3.18% | 5.25% | 8.14% | 8.29% |
| DaVita Inc. (DVA)vs › | $11.80B | 10.58% | 10.99% | 9.48% | 9.31% |
| Oscar Health, Inc. (OSCR)vs › | $7.23B | -27.10% | -12.21% | -19.73% | -18.73% |
ROIC
13.6%
ROE
26.4%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 13.62% |
| 2024-12-31 | 11.68% |
| 2023-12-31 | 9.66% |
| 2022-12-31 | 0.92% |
| 2021-12-31 | 5.58% |
| 2020-12-31 | 2.14% |
| 2019-12-31 | 4.05% |
| 2018-12-31 | 2.14% |
| 2017-12-31 | -1.01% |
| 2016-12-31 | -2.67% |
| 2015-12-31 | -22.62% |
| 2014-12-31 | -3.40% |
| 2013-12-31 | -11.74% |
| 2012-12-31 | -21.91% |
| 2011-12-31 | -18.79% |
| 2010-12-31 | -28.14% |
| 2009-12-31 | -39.09% |
| 2008-12-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2004-12-31 | 667.91% |
| 2003-12-31 | 0.00% |
| 2002-12-31 | 0.00% |
